Fri, October 22, 2021
Thu, October 21, 2021
Wed, October 20, 2021
Tue, October 19, 2021
Mon, October 18, 2021
Sun, October 17, 2021
Fri, October 15, 2021
Thu, October 14, 2021

Ami Fadia Maintained (BIIB) at Strong Buy with Decreased Target to $398 on, Oct 19th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-398-on-oct-19th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ami Fadia of Needham, Maintained "Biogen Inc." (BIIB) at Strong Buy with Decreased Target from $400 to $398 on, Oct 19th, 2021.

Ami has made no other calls on BIIB in the last 4 months.



There are 9 other peers that have a rating on BIIB. Out of the 9 peers that are also analyzing BIIB, 4 agree with Ami's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $327 on, Friday, October 15th, 2021
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $290 on, Friday, October 8th, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $326 on, Wednesday, September 29th, 2021
  • Salim Syed of "Mizuho" Maintained at Hold with Increased Target to $300 on, Monday, August 2nd, 2021


These are the ratings of the 5 analyists that currently disagree with Ami


  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $344 on, Friday, October 15th, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $447 on, Tuesday, October 12th, 2021
  • Michael Yee of "Jefferies" Maintained at Strong Buy with Decreased Target to $400 on, Friday, October 8th, 2021
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $442 on, Thursday, September 16th, 2021
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $423 on, Tuesday, July 27th, 2021

Publication Contributing Sources